| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $32K | — | -84.1% |
| Cost of Revenue | $15K | — | -96.5% |
| Gross Profit | $17K | — | -97.6% |
| R&D Expense | $666K | — | +83.1% |
| SG&A Expense | $478K | — | +83.9% |
| Operating Income | -$1.1M | — | +48.8% |
| Net Income | -$963K | — | -165.3% |
| EPS (Basic) | -$0.15 | — | -100.8% |
| EPS (Diluted) | -$0.15 | — | -100.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.8M | +76.5% | +249.7% |
| Accounts Receivable | $309 | -4.9% | -100.0% |
| Current Assets | $9.2M | +68.5% | +45.6% |
| Total Assets | $10.2M | +56.8% | +57.1% |
| Current Liabilities | $2.1M | -21.6% | -48.0% |
| Total Liabilities | $2.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.4M | — | +32.2% |
| Financing Cash Flow | $5.3M | — | +34.0% |
| -59.2% |
| Stockholders' Equity | $8.0M | +113.8% | +553.8% |